Lv4
430 积分 2024-01-10 加入
Phase 1 Dose-Escalation Study of [ 225 Ac]Ac-PSMA I&T in Patients with Metastatic Castration-Resistant Prostate Cancer: An Analysis of Safety, Tolerability, and Dosimetry
4天前
已完结
Artificial intelligence in drug discovery — what it is, where we stand and the path forward
5天前
已完结
Application of Bioisosteres in the Design and Discovery of FDA-Approved Drugs and Advanced Clinical Candidates
1个月前
已完结
Retrospective Analysis of the Impact of the “Escape from Flatland” Publication on the Merck & Co., Inc., Small Molecule Portfolio
1个月前
已完结
Alpha-Particle Therapy with an Actinium-225 Labeled Bivalent Inhibitor of Prostate-Specific Membrane Antigen is Therapeutically Efficacious in a Mouse Model of Prostate Cancer
1个月前
已完结
Validation of a New Methodology to Create Oral Drugs beyond the Rule of 5 for Intracellular Tough Targets
1个月前
已完结
Imbuing peptide libraries with drug-likeness
1个月前
已完结
Validation of a New Methodology to Create Oral Drugs beyond the Rule of 5 for Intracellular Tough Targets
1个月前
已完结
Development of Orally Bioavailable Peptides Targeting an Intracellular Protein: From a Hit to a Clinical KRAS Inhibitor
1个月前
已完结
Synthetic Approaches to the New Drugs Approved During 2024
2个月前
已完结
皖公网安备34019202002308
